PPD is a holding company. Through its subsidiaries, Co. provides drug development services to the biopharmaceutical industry. Co. provides a suite of clinical development and laboratory services to pharmaceutical, biotechnology, medical device and government organizations, and other industry. Co.'s service offerings include both clinical development and laboratory services. Co.'s clinical development services include all phases of development (i.e., Phase I-IV), peri- and post-approval and site and patient access services. Co.'s laboratory services provide a range of testing services, including bioanalytical, biomarker, vaccine, good manufacturing practice and central laboratory services. We show 7 historical shares outstanding datapoints in our PPD shares outstanding history coverage, used to compute PPD market cap on those dates.
Understanding the changing numbers of shares outstanding, the changing
share price, and the resulting changing PPD market cap history over the course of time is important for investors
interested in comparing PPD's market cap history versus its peers.
Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at
a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies,
and then calculating their respective market caps. Comparing the share price of PPD versus a peer is one thing; comparing
PPD market cap versus a peer is a completely different story.
Furthermore, via fluctuation both in per-share price and in the number of shares outstanding (via issuance of new shares over time, the repurchase of existing shares),
the market cap for a company like PPD can fluctuate over the course of history.
With this page we aim to empower investors researching PPD by allowing them to research the PPD market cap history. |
Free PPD Email Alerts:
Video: The Importance of Market Cap
